Despite over 100 years of insulin therapy, glycemia remains suboptimal for many individuals
living with diabetes. Data from international diabetes registries highlight that most youth with …

Young patients with diabetes, their families, and their diabetes care providers continue to be
faced with the challenge of striving to maintain blood glucose levels in the near-normal …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

Since the last guidelines were published in 2009 (1) the changes have been modest with
respect to insulin treatment, but the different modes have been refined especially when it …

Aims To determine the impact of insulin pump therapy (continuous subcutaneous insulin
infusion) on key parameters of diabetes management including quality of life in children and …

This article is a chapter in the ISPAD Clinical Practice Consensus Guidelines 2009
Compendium. The complete set of guidelines can be found at www. ispad. org. The …

OBJECTIVE: To examine the effect of continuous subcutaneous insulin infusion (CSII)
therapy on parameters affecting long-term outcome in type 1 diabetes. STUDY DESIGN …

The introduction of continuous subcutaneous insulin infusion in clinical care has led to more
optimal glycemic and quality-of-life outcomes, compared with multiple daily injections (MDI) …

Background: There are currently few data available on the long-term use of continuous
subcutaneous insulin infusion (CSII)(insulin pump) therapy in children. Methods: Charts from …

This review summarizes the technologies in use and in the pipeline for the management of
diabetes. The review focuses on glucose meters, continuous glucose monitoring devices …